This panel explores partnerships between Swiss biotech companies and Japanese pharmaceutical firms, focusing on key advantages, challenges, and cultural alignment. It will also examine alternatives to equity financing and share practical insights into structuring and sustaining successful cross-border collaborations.
Monday, May 4, 15:30 - 16:15, room Shanghai 3+4
| Name | Position | Institution |
|---|---|---|
| Dragan Grabulowski | Araris | |
| Barbara Angehrn | Numab | |
| Marc Gitzinger | BioVersys | |
| Julia Schieber | Baker McKenzie |
Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members in a competitive market, the Swiss Biotech Association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources. To strengthen and promote the Swiss biotech industry, the Swiss Biotech Association collaborates with numerous partners and life science clusters globally under the brand Swiss Biotech™.
